Valuation: Labcorp Holdings Inc.

Capitalization 22.03B 18.89B 17.67B 16.5B 30.72B 1,979B 33.28B 207B 79.98B 935B 82.69B 80.93B 3,410B P/E ratio 2025 *
22.5x
P/E ratio 2026 * 19.4x
Enterprise value 26.86B 23.03B 21.54B 20.11B 37.45B 2,412B 40.57B 253B 97.5B 1,140B 101B 98.65B 4,156B EV / Sales 2025 *
1.92x
EV / Sales 2026 * 1.8x
Free-Float
99.96%
Yield 2025 *
1.08%
Yield 2026 * 1.1%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.61%
1 week-2.72%
Current month-2.72%
1 month+3.63%
3 months-5.00%
6 months+2.80%
Current year+14.02%
More quotes
1 week 259.42
Extreme 259.42
272.82
1 month 244.52
Extreme 244.52
272.82
Current year 209.38
Extreme 209.375
293.72
1 year 209.38
Extreme 209.375
293.72
3 years 191.97
Extreme 191.97
293.72
5 years 191.97
Extreme 191.97
317.17
10 years 97.79
Extreme 97.79
317.17
More quotes
Change 5d. change 1-year change 3-years change Capi.($)
-1.61%-2.72%+10.15%+10.61% 22.03B
+0.18%-4.06%+50.47%+107.21% 111B
+2.33%-4.49%+32.21%-24.76% 95.21B
+1.69%+1.31%+41.75%+77.49% 31.13B
+2.20%+2.57%-8.79%+7.35% 22.92B
+0.86%-2.64%+14.94%+23.68% 20.31B
+3.34%+2.80%+76.12%+62.29% 19.06B
+0.38%-2.17%+49.91%+375.65% 18.57B
+0.19%-5.35%+15.80%+81.05% 14.38B
-1.14%-2.94%-9.95%+28.73% 13.5B
Average +0.82%-2.93%+27.26%+74.93% 36.82B
Weighted average by Cap. +0.79%-4.06%+34.68%+61.28%
See all sector performances

Financials

2025 *2026 *
Net sales 14B 12B 11.22B 10.48B 19.52B 1,257B 21.14B 132B 50.81B 594B 52.53B 51.41B 2,166B 14.62B 12.53B 11.72B 10.95B 20.38B 1,313B 22.08B 138B 53.07B 620B 54.86B 53.69B 2,262B
Net income 939M 805M 753M 704M 1.31B 84.38B 1.42B 8.84B 3.41B 39.87B 3.53B 3.45B 145B 1.08B 927M 867M 810M 1.51B 97.16B 1.63B 10.18B 3.93B 45.91B 4.06B 3.97B 167B
Net Debt 4.82B 4.14B 3.87B 3.61B 6.73B 433B 7.29B 45.39B 17.52B 205B 18.11B 17.72B 747B 4.22B 3.61B 3.38B 3.16B 5.88B 379B 6.37B 39.65B 15.3B 179B 15.82B 15.48B 652B
More financial data * Estimated data
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.
Employees
65,450
More about the company
Date Price Change Volume
25-12-04 261.48 $ -1.61% 853,078
25-12-03 265.76 $ -0.06% 709,581
25-12-02 265.93 $ -0.67% 659,370
25-12-01 267.73 $ -0.39% 766,999
25-11-28 268.78 $ +0.19% 313,057

Delayed Quote Nyse, December 04, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
265.76USD
Average target price
299.71USD
Spread / Average Target
+12.77%
Consensus

Quarterly revenue - Rate of surprise